UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Trims Stake in Option Care Health, Inc. (NASDAQ:OPCH)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC reduced its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 35.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,610,085 shares of the company's stock after selling 1,435,488 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 1.53% of Option Care Health worth $60,554,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in the business. JPMorgan Chase & Co. boosted its stake in Option Care Health by 29.6% during the 4th quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company's stock valued at $35,065,000 after purchasing an additional 344,875 shares during the last quarter. MetLife Investment Management LLC boosted its position in shares of Option Care Health by 7.8% during the fourth quarter. MetLife Investment Management LLC now owns 197,219 shares of the company's stock valued at $4,575,000 after buying an additional 14,311 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in Option Care Health by 6.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock worth $58,235,000 after buying an additional 147,054 shares in the last quarter. Global Alpha Capital Management Ltd. raised its position in Option Care Health by 38.1% in the 4th quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company's stock valued at $1,596,000 after buying an additional 18,992 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new stake in Option Care Health in the 4th quarter valued at $327,000. 98.05% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, insider Michael Bavaro sold 30,996 shares of the business's stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. The trade was a 40.80% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.64% of the company's stock.

Wall Street Analysts Forecast Growth

OPCH has been the subject of several recent analyst reports. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. JPMorgan Chase & Co. increased their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a research note on Thursday, March 6th. Barrington Research restated an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research note on Wednesday, April 30th. Finally, JMP Securities reaffirmed a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a report on Tuesday, April 22nd. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, Option Care Health presently has an average rating of "Moderate Buy" and a consensus price target of $35.50.

Option Care Health Stock Performance

Shares of OPCH stock traded down $0.38 on Wednesday, hitting $31.74. 881,761 shares of the stock were exchanged, compared to its average volume of 1,858,425. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The firm's 50 day moving average is $32.89 and its two-hundred day moving average is $29.47. The firm has a market capitalization of $5.20 billion, a PE ratio of 26.67, a P/E/G ratio of 2.30 and a beta of 0.76. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its earnings results on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The company's revenue was up 16.3% on a year-over-year basis. During the same quarter last year, the company earned $0.26 earnings per share. Sell-side analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.